Portfolio company SonoClear AS completed final patient procedure in its clinical trial for its breakthrough-designated intracranial ultrasound system.
SonoClear is dedicated to improving the intraoperative accuracy of ultrasound to assist neurosurgeons in tumor resections
SonoClear is dedicated to improving the intraoperative accuracy of ultrasound to assist neurosurgeons in tumor resections. Their product, the SonoClear® System, is an advanced acoustic couplant designed to enhance ultrasound imaging clarity.